Groningen, Netherlands · Founded 2023 · Privately Held (backing)
Developer of a biotechnological platform designed for single-domain antibody (sdAb) discovery and development. Cortalix is based in Groningen, Netherlands and was founded in 2023. It has raised $1.3 million.
Last price · $/share
—
Implied valuation
—
Total raised
$1.3M
Last round
—
Team — not yet on record
No current team members for Cortalix are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cortalix with a free account
·Watch Cortalix: the Monday email on marks, rounds and moves
